US FDA Evaluating Effectiveness of COVID-19 Vaccines vs. Omicron

Published on November 30, 2021

The U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against the omicron coronavirus variant and expects to have more information in the next few weeks.

Read Full Article (External Site)